Dark

EXAS
Exact Sciences Corp
stock NASDAQ

At Close

May 8, 2025 3:59:57 PM EDT

53.06USD-0.413%(-0.22)1,974,673

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 8, 2025 9:09:30 AM EDT

53.15USD-0.244%(-0.13)1,537

After-hours

May 8, 2025 4:40:30 PM EDT

53.06USD0.000%(0.00)45,084

Jan 18, 2022

05:20PM EST Exact Sciences Presents Data On Accuracy Of Second-Generation Cologuard Test, Progress Toward An Even Better Colorectal Cancer Screening Solution For Patients Benzinga

05:18PM EST Cologuard(r) Test and Progress Toward an Even Better Colorectal Cancer Screening Solution for Patients PR Newswire

Jan 10, 2022

11:19AM EST Exact Sciences Option Alert: Apr 14 $77.5 Calls Sweep (12) above Ask!: 1033 @ $6.5 vs 13 OI; Earnings 2/15 After Close [est] Ref=$71.62 Benzinga

Jan 9, 2022

08:53PM EST Exact Sciences Corp. (EXAS) said it has acquired PreventionGenetics, a genetic testing laboratory, to complement its advanced cancer diagnostics portfolio and support its entrance into hereditary cancer testing or HCT, for total consideration of $190 million in stock and cash. RTTNews

07:00PM EST Exact Sciences Announces Preliminary Fourth Quarter 2021 Results PR Newswire

07:00PM EST Exact Sciences and OncXerna Announce Licensing Agreement to Help Predict PR Newswire

07:00PM EST Exact Sciences Acquires PreventionGenetics to Accelerate Availability of PR Newswire

Jan 3, 2022

06:00AM EST Exact Sciences to participate in J.P. Morgan Healthcare Conference PR Newswire

Dec 8, 2021

11:30AM EST New Data Presented at SABCS(r) 2021 Strengthen Value of Oncotype DX Breast PR Newswire

05:29AM EST Exact Sciences Announced Presentation of New Data at San Antonio Breast Cancer Symposium Supporting Clinical Value of the Oncotype DX Breast Recurrence Score Test Benzinga

Dec 1, 2021

05:07PM EST Exact Sciences Highlights Publication Of New England Journal Of Medicine Confirms Women With Node-Positive, Early-Stage Breast Cancer Can Avoid Chemo With Oncotype DX Test Benzinga

05:05PM EST Thousands of Women with Node-positive, Early-stage Breast Cancer Can Avoid Chemotherapy with the Oncotype DX(r) Test PR Newswire

Nov 30, 2021

04:47PM EST The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout Benzinga

04:42PM EST Pfizer Will Not Co-Promote Exact Sciences Colorectal Cancer Screening Test Benzinga

04:29PM EST Exact Sciences And Pfizer Enter Amendment To Amended & Restated Cologuard Promotion Agreement; Exact To Pay Pfizer $35,900,000 In Three Installments During Q2, Q3 And Q4 Of 2022 Benzinga

Nov 23, 2021

09:10AM EST Exact Sciences Highlights New 20-Year Data Published In 'Urologic Oncology' Validates Adverse Pathology As Predictor Of Prostate Cancer Outcomes In Low-Risk Patients Benzinga

09:09AM EST New 20-Year Data Published in Urologic Oncology Validates Adverse Pathology as PR Newswire

Nov 18, 2021

08:32AM EST Exact Sciences Reports Begun Collab With Jefferson Health On Multi-Cancer Earlier Detection Benzinga

08:31AM EST Exact Sciences and Jefferson Health Commence Collaboration on Multi-Cancer PR Newswire

Nov 4, 2021

08:14AM EDT Section 32 Raises $740 Million Venture Fund PR Newswire

Nov 3, 2021

10:03AM EDT Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2021 Benzinga

09:16AM EDT Wells Fargo Maintains Equal-Weight on Exact Sciences, Lowers Price Target to $95 Benzinga

09:16AM EDT 10 Biggest Price Target Changes For Wednesday Benzinga

09:15AM EDT SVB Leerink Maintains Outperform on Exact Sciences, Lowers Price Target to $140 Benzinga

09:13AM EDT Raymond James Downgrades Exact Sciences to Outperform, Lowers Price Target to $130 Benzinga

Nov 2, 2021

06:05PM EDT Exact Sciences Sees FY21 Sales $1.722B-$1.737B vs $1.73B Estimate Benzinga

06:04PM EDT Exact Sciences Q3 Adj. EPS $(0.79) Beats $(0.85) Estimate, Sales $456.38M Beat $430.03M Estimate Benzinga

04:05PM EDT Exact Sciences announces third quarter 2021 results PR Newswire

10:54AM EDT The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US Benzinga

10:41AM EDT Earnings Scheduled For November 2, 2021 Benzinga

Nov 1, 2021

09:04AM EDT Cathie Wood's ARK Invest Posts Fund Purchases For Friday, Oct. 29, 2021: NTLA, PACB, ACHR, MKFG, BLDE, FB, CDNA, DOC, EXAS, VERV, BEAM Benzinga

06:01AM EDT Exact Sciences to participate in November investor conferences PR Newswire

Oct 31, 2021

02:24PM EDT The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline Benzinga

Oct 25, 2021

05:34PM EDT New Cologuard(r) Modeling Data Show Patient Navigation Matters When Reaching PR Newswire

Oct 8, 2021

06:00AM EDT Exact Sciences schedules third quarter 2021 earnings call PR Newswire

Sep 15, 2021

08:18AM EDT UPDATE: Exact Sciences Completed Expedited Hiring Process For Its Cologuard Sales Team, Onboarded ~400 Sales Reps In Sept., Increased Size Of Its Primary Care Field Sales Team To 850+ Reps Benzinga

08:16AM EDT Exact Sciences 8-K Shows Co. Expanded Its Primary Care Sales Team To Increase Adoption Of Cologuard, Its Pipeline Of Cancer Screening Tests Benzinga

Sep 14, 2021

05:05AM EDT Exact Sciences and National Surgical Adjuvant Breast and Bowel Project Announced Clinical Validation Study to Detect Minimal Residual Disease in Colorectal Cancer Patients Benzinga

Sep 1, 2021

12:14PM EDT Exact Sciences Shares See Volume, Traders Circulate UnitedHealthCare Report Highlighting Updated Preventive Care Services Policy Lowered Age For Colorectal Cancer Screening From 50-75 To 45-75; BZ Note: Exact Sciences Has Cologuard Screening Service Benzinga

06:00AM EDT Exact Sciences to participate in September investor conferences PR Newswire

Aug 30, 2021

07:00AM EDT Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) today announced the appointment of Daniel J. Levangie to the Companys board of directors. Mr. Levangie is also appointed as a member of the Companys remuneration committee. GlobeNewswire Inc

Aug 16, 2021

06:02AM EDT Exact Sciences Says Japan's Ministry Of Health, Labor And Welfare Approves Oncotype DX Breast Recurrence Score Program RTTNews

06:02AM EDT Exact Sciences Receives Regulatory Approval For The Oncotype DX Breast Recurrence Score Program In Japan Benzinga

06:00AM EDT Exact Sciences receives regulatory approval for the Oncotype DX Breast PR Newswire

Aug 13, 2021

09:03AM EDT Exact Sciences' Oncoguard Liver Liquid Biopsy Test Delivers Enhanced Performance For Early-stage Detection Of HCC RTTNews

09:01AM EDT Exact Sciences Corp. Highlights Publication Of Oncoguard Performance Data In Clinical Gastroenterology and Hepatology Journal Benzinga

09:00AM EDT Oncoguard(tm) Liver Liquid Biopsy Test Delivers Enhanced Performance for Early-stage Detection of Hepatocellular Carcinoma PR Newswire

Jul 29, 2021

03:40PM EDT Expert Ratings for Exact Sciences Benzinga

12:15PM EDT Canaccord Genuity Maintains Buy on Exact Sciences, Lowers Price Target to $160 Benzinga

09:02AM EDT Oppenheimer Maintains Outperform on Exact Sciences, Lowers Price Target to $155 Benzinga

08:18AM EDT The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs Benzinga

Jul 28, 2021

04:28PM EDT Exact Sciences: Q2 Earnings Insights Benzinga

04:21PM EDT Exact Sciences Raises FY21 Revenue Guidance From $1.69B-$1.735B To $1.705B-$1.745B vs $1.72B Est. Benzinga

04:19PM EDT Exact Sciences Q2 EPS $(1.03) Misses $(0.76) Estimate, Sales $434.80M Beat $421.28M Estimate Benzinga

04:06PM EDT Exact Sciences Announces Second Quarter 2021 Results PR Newswire

07:33AM EDT The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal Benzinga

04:27AM EDT Earnings Scheduled For July 28, 2021 Benzinga

Jul 25, 2021

10:05AM EDT The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More Benzinga

Jul 14, 2021

07:48AM EDT SVB Leerink Maintains Outperform on Exact Sciences, Lowers Price Target to $160 Benzinga

Jul 8, 2021

06:00AM EDT Exact Sciences schedules second quarter 2021 earnings call PR Newswire

Jul 2, 2021

02:41PM EDT Watching Exact Sciences Shares; Seeing Reports On Social Media Co Grated FDA Emergency Use Authorization For COVID-Flu Multiplex Assay Benzinga

Jun 21, 2021

07:53AM EDT 10 Biggest Price Target Changes For Monday Benzinga

07:04AM EDT Wells Fargo Maintains Equal-Weight on Exact Sciences, Raises Price Target to $120 Benzinga

Jun 15, 2021

10:24AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021 Benzinga

07:35AM EDT Raymond James Initiates Coverage On Exact Sciences with Strong Buy Rating, Announces Price Target of $160 Benzinga

Jun 8, 2021

08:51AM EDT Cramer Gives His Opinion On Novavax, Exact Sciences And More Benzinga

Jun 3, 2021

10:09AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2021 Benzinga

06:37AM EDT Goldman Sachs Initiates Coverage On Exact Sciences with Buy Rating, Announces Price Target of $160 Benzinga

May 25, 2021

10:02AM EDT Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021 Benzinga

07:22AM EDT Wells Fargo Initiates Coverage On Exact Sciences with Equal-Weight Rating, Announces Price Target of $115 Benzinga

May 24, 2021

06:00AM EDT Exact Sciences to participate in June investor conferences PR Newswire

May 21, 2021

08:03AM EDT Exact Sciences Highlights Data Being Featured At 2021 Digestive Disease Week May 21-23 Benzinga

08:00AM EDT Modeling Data Showed Cologuard(r) Was Superior to Fecal Immunochemical Test PR Newswire

May 19, 2021

05:25PM EDT Pharma/Biotech Companies Highlight Upcoming Presentations At American Society Of Clinical Oncology Jun. 4-8, 2021 Benzinga

05:15PM EDT Exact Sciences Strengthens Evidence Supporting Cologuard(r) and Oncotype DX(r) PR Newswire

May 18, 2021

08:58PM EDT Exact Sciences Welcomes Final Task Force Recommendation That Lowers Starting Age For Colorectal Cancer Screening To 45 RTTNews

08:06PM EDT Exact Sciences Applauds Final Task Force Recommendation That Lowers Starting PR Newswire

May 12, 2021

08:08AM EDT Truist Securities Maintains Buy on Exact Sciences, Lowers Price Target to $168 Benzinga

May 5, 2021

08:00AM EDT 10 Biggest Price Target Changes For Wednesday Benzinga

06:43AM EDT SVB Leerink Maintains Outperform on Exact Sciences, Lowers Price Target to $170 Benzinga

May 4, 2021

04:01PM EDT Exact Sciences Sees FY21 Sales $1.69B-$1.735B vs $1.72B Est. Benzinga

04:00PM EDT Exact Sciences Announces First Quarter 2021 Results PR Newswire

04:00PM EDT Exact Sciences Q1 EPS $(0.18) Beats $(1.03) Estimate, Sales $402.10M Beat $388.57M Estimate Benzinga

08:10AM EDT The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data Benzinga

May 3, 2021

06:01AM EDT Exact Sciences to participate in May investor conferences PR Newswire

Apr 28, 2021

06:00AM EDT Cologuard(r) CRC Screening Test Most Cost-Effective Test in Medically PR Newswire

Apr 14, 2021

06:03AM EDT Exact Sciences Completes Acquisition Of Ashion Analytics RTTNews

06:00AM EDT Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The PR Newswire

Apr 8, 2021

06:00AM EDT Exact Sciences schedules first quarter 2021 earnings call PR Newswire

Mar 30, 2021

12:10PM EDT Ark Funds, Illumina Invest In SomaLogic SPAC Deal: What Investors Should Know Benzinga

Mar 2, 2021

06:54PM EST ARK Invest's Cathie Wood To Appear On Benzinga's 'The Raz Report' Wednesday, Mar. 3, 2021 At 2 p.m. EST; Register Early For A Chance To Win To Ask Cathie A Question Live On Air Benzinga

Feb 22, 2021

06:00AM EST Exact Sciences to participate in March investor conferences PR Newswire

Feb 17, 2021

07:02PM EST Cathie Wood's ARK Invest Posts Fund Purchases For Wednesday, Feb. 17, 2021: ABBV, VEEV, SGFY, EXAS, CMLF, BFLY, TSLA, SHOP, NTDOY, IRDM, FATE, BEAM, TDY, RAVN, KMTUY Benzinga

02:55PM EST Why Exact Sciences Stocks Is Trading Lower Today Benzinga

12:05PM EST Stifel Maintains Buy on Exact Sciences, Raises Price Target to $165 Benzinga

12:01PM EST Cowen & Co. Maintains Outperform on Exact Sciences, Raises Price Target to $180 Benzinga

08:36AM EST 10 Biggest Price Target Changes For Wednesday Benzinga

07:27AM EST The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal Benzinga

06:04AM EST SVB Leerink Maintains Outperform on Exact Sciences, Raises Price Target to $180 Benzinga

Feb 16, 2021

04:45PM EST Recap: Exact Sciences Q4 Earnings Benzinga

04:44PM EST Exact Sciences Q4 Adj EPS $(0.15) Beats $(0.22) Est., Sales $466.30M Beat $446.22M Estimate Benzinga

04:44PM EST UPDATE: Exact Sciences Q4 Adj EPS $(0.15) Beats $(0.22) Est. Benzinga

04:18PM EST Exact Sciences to Acquire Ashion Analytics and Enter Research Collaboration with City of Hope's Genomics Institute, TGen; No Terms Were Disclosed Benzinga

04:07PM EST Exact Sciences Q4 EPS $(2.79) May Not Compare To $(0.22) Estimate, Sales $466.30M Beat $446.22M Estimate Benzinga

04:06PM EST Exact Sciences Announces Fourth Quarter 2020 Results PR Newswire

04:06PM EST Exact Sciences to Acquire Ashion Analytics and Enter Research Collaboration PR Newswire

06:49AM EST Earnings Scheduled For February 16, 2021 Benzinga

Feb 15, 2021

10:34AM EST A Preview Of Exact Sciences's Earnings Benzinga

Feb 8, 2021

08:26AM EST Sema4 Appoints Isaac Ro As Chief Financial Officer Benzinga

Feb 1, 2021

06:01AM EST Exact Sciences schedules fourth quarter 2020 earnings call PR Newswire

06:01AM EST Exact Sciences to participate in February investor conferences PR Newswire

Jan 28, 2021

10:04AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 28, 2021 Benzinga

07:03AM EST Truist Securities Initiates Coverage On Exact Sciences with Buy Rating, Announces Price Target of $226 Benzinga

Jan 26, 2021

08:07AM EST The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market Benzinga

Jan 21, 2021

08:05AM EST The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping Benzinga

07:58AM EST SVB Leerink Maintains Outperform on Exact Sciences, Raises Price Target to $170 Benzinga

Jan 13, 2021

02:48PM EST Exact Sciences Licenses Targeted Digital Sequencing Method To 'Extend Leadership In Precision Oncology' Benzinga

02:45PM EST Exact Sciences Licenses Targeted Digital Sequencing Method to Extend Leadership PR Newswire

07:25AM EST The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations Benzinga

Jan 12, 2021

02:47PM EST Exact Sciences Highlights Data Published In 'Cancer Prevention Research' For Low False-Positive Rate For Screening Average-Risk People Age 45-49 For Colorectal Cancer With Cologuard Benzinga

02:45PM EST New Prospective Data Demonstrate Low False-Positive Rate for Screening PR Newswire

08:16AM EST The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue Benzinga

Jan 11, 2021

10:34AM EST Shares of molecular diagnostics company Exact Sciences Corporation (EXAS) are rising more than 14% Monday morning after reporting fourth-quarter and full-year preliminary revenue, better than analysts' view. RTTNews

09:37AM EST Exact Sciences On Sunday Announces The Company Expects Q4 Sales of $464.5M-$467.5M Vs. $431.18M Est. Benzinga

Jan 10, 2021

10:26PM EST Exact Sciences Corp. (EXAS) said that it expects revenue to be between $464.5 million and $467.5 million for the fourth quarter ended December 31, 2020. Analysts polled by Thomson Reuters expect the company to report revenues of $431.18 million for the fourth-quarter. Analysts' estimates typically exclude special items. RTTNews

07:54PM EST Exact Sciences Expects Q4 Total Revenue Of $464.5 Mln- $467.5 Mln RTTNews

07:30PM EST Exact Sciences Announces Preliminary Fourth Quarter 2020 Results PR Newswire

Jan 5, 2021

08:40AM EST Exact Sciences Completes Acquisition Of Thrive Earlier Detection RTTNews

08:26AM EST Exact Sciences Completes Acquisition of Thrive Earlier Detection, Creating a PR Newswire

Dec 28, 2020

06:00AM EST Exact Sciences to participate in J.P. Morgan Healthcare Conference PR Newswire

Dec 23, 2020

11:31AM EST Cramer Weighs In On Salesforce, General Motors And More Benzinga

08:31AM EST The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut Benzinga

Dec 22, 2020

07:45AM EST The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes Benzinga

Dec 11, 2020

09:04AM EST Exact Sciences Says Oncotype DX Breast Recurrence Score Test Data Highlight The Role Of The Test In Further Individualizing Treatment Decisions In Early Breast Cancer Benzinga

09:03AM EST Exact Sciences Announces Presentation Of New Data At SABCS 2020 Benzinga

09:00AM EST New Data at SABCS 2020 Highlight the Role of the Oncotype DX Breast Recurrence PR Newswire

Dec 9, 2020

03:13PM EST Exact Sciences Shares Volatile On Volume Spike; Traders Circulate Word House Passed Bill Waiving Medicare Coinsurance Requirements Related To Colorectal Cancer Screening Tests Benzinga

09:13AM EST Exact: Oncotype DX Test Can Now Spare Chemotherapy Use In Majority Of Women With Node-positive Early-stage Breast Cancer RTTNews

09:04AM EST UPDATE: Exact Sciences Says First Results From Independent SWOG Cancer Research Network-Led Phase III Study To Be Presented At 2020 San Antonio Breast Cancer Symposium Benzinga

09:02AM EST Exact Sciences Reports Data From RxPONDER Study Benzinga

09:02AM EST Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer PR Newswire

Dec 8, 2020

08:27AM EST Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Dec. 8, 2020: VBK, EXAS, TSM, AMC, RGLS Benzinga

Dec 7, 2020

03:30PM EST UPDATE: Cowen On Exact Sciences Does Not See New House Bill On Multi-Cancer Screening As Likely To Move The Stock In the Near Term Benzinga

03:29PM EST Watching Exact Sciences Shares As Traders Circulate Word Of Caution From Cowen Benzinga

Nov 23, 2020

06:00AM EST Exact Sciences to participate in December investor conference PR Newswire

Nov 17, 2020

08:03AM EST Leading Diagnostics Companies Join Forces to Establish the Access to PR Newswire

Nov 2, 2020

06:00AM EST Exact Sciences to participate in November investor conferences PR Newswire

Oct 29, 2020

09:28AM EDT UBS Downgrades Exact Sciences to Neutral, Raises Price Target to $140 Benzinga

07:30AM EDT The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal Benzinga

Oct 28, 2020

12:38PM EDT Benzinga's Top Upgrades, Downgrades For October 28, 2020 Benzinga

11:26AM EDT Canaccord Genuity Maintains Buy on Exact Sciences, Raises Price Target to $145 Benzinga

10:12AM EDT Exact Sciences shares are trading lower after Citigroup downgraded the stock from Buy to Neutral. Benzinga

09:37AM EDT 10 Biggest Price Target Changes For Wednesday Benzinga

08:19AM EDT Citigroup Downgrades Exact Sciences to Neutral, Raises Price Target to $140 Benzinga

07:35AM EDT Benchmark Maintains Buy on Exact Sciences, Raises Price Target to $145 Benzinga

06:23AM EDT SVB Leerink Maintains Outperform on Exact Sciences, Raises Price Target to $160 Benzinga

Oct 27, 2020

04:43PM EDT Exact Sciences Highlights US Preventive Services Task Force Draft Updated Guidelines For Colorectal Cancer Screening To Begin At Age Of 45, Including Co.'s Cologuard Benzinga

04:35PM EDT Exact Sciences Commends Task Force for Draft Updated Guidelines that include PR Newswire

03:35PM EDT Canaccord Genuity Reiterates Buy Rating On Exact Sciences, Raises Price Target From $120 To $145 Benzinga

02:59PM EDT Hearing Evercore Raised Exact Sciences Price Target From $120 To $160 Benzinga

10:29AM EDT Exact Sciences's Debt Overview Benzinga

10:03AM EDT Shares of cancer screening and diagnostic tests provider Exact Sciences Corporation (EXAS) are rising more than 17% Tuesday morning after the company said it has agreed to buy Thrive Earlier Detection Corp. for about $2.15 billion, cash and stock. RTTNews

09:56AM EDT Looking Into Exact Sciences's Return On Capital Employed Benzinga

09:01AM EDT Stocks Trading Near 52-Week Highs Before Open On Tuesday, Oct. 27, 2020: XLNX, CROX, KOD, VRNS, EXAS, CMI, TPB Benzinga

08:25AM EDT The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings Benzinga

07:37AM EDT Exact Sciences Q3 Net Loss $219.9 Mln Vs. Net Loss $40.5 Mln Last Year RTTNews

07:36AM EDT Exact Sciences Reports Sale Of 8.605M Shares Of Common Stock At $101/Share Benzinga

07:10AM EDT Exact Sciences Announces Entry into Agreements to Sell $869 Million of Common PR Newswire

07:10AM EDT Exact Sciences To Acquire Thrive Earlier Detection For $2.15B In Cash And Stock Benzinga

07:09AM EDT Exact Sciences Q3 EPS $(1.46) Misses $(0.52) Estimate, Sales $408.40M Beat $337.37M Estimate Benzinga

07:02AM EDT Exact Sciences Announces Third Quarter 2020 Results PR Newswire

07:02AM EDT Exact Sciences To Acquire Thrive Earlier Detection, Becoming A Leader In PR Newswire

Oct 12, 2020

09:03AM EDT Exact Sciences Introduces The Oncotype MAP Pan-Cancer Tissue Test To Help Guide Treatment For Patients With Advanced Cancer Benzinga

09:00AM EDT Exact Sciences Introduces the Oncotype MAP(tm) Pan-Cancer Tissue Test to Help PR Newswire

Oct 9, 2020

06:00AM EDT Exact Sciences schedules third quarter 2020 earnings call PR Newswire

Oct 7, 2020

06:13AM EDT Exact Sciences And Pfizer Extend And Amend Cologuard Promotion Agreement RTTNews

Sep 25, 2020

11:49AM EDT Canaccord Genuity Maintains Buy on Exact Sciences, Raises Price Target to $120 Benzinga

09:23AM EDT ROCE Insights For Exact Sciences Benzinga

08:30AM EDT Benzinga Pro's Top 4 Stocks To Watch For Friday, Sept. 25, 2020: ASAN, EXAS, SGBX, SINA Benzinga

Sep 24, 2020

12:11PM EDT Why Exact Sciences Stock Is Trading Higher Today Benzinga

11:47AM EDT Exact Sciences Option Alert: Jan 15 $82.5 Calls at the Ask: 50 @ $16.7 vs 324 OI; Earnings 10/27 After Close [est] Ref=$94.14 Benzinga

10:57AM EDT UPDATE: Exact Sciences CEO Says Co. Will Be The Leader In Liquid Biopsy Market Over Next 5 Years; Webcast With Cowen Concludes Benzinga

10:57AM EDT Exact Sciences CEO Concluding Presentation At Cowen Webcast; When Asked What Is Most Exciting Thing About Liquid Biopsy Market Over Next Five Years, Highlights Multi-Cancer Screening, Blood-Based Cancer Screening Benzinga

Sep 17, 2020

06:00AM EDT Exact Sciences to participate in Cowen Liquid Biopsy Summit PR Newswire

Sep 1, 2020

04:11PM EDT Exact Sciences to participate in September investor conference PR Newswire

Aug 31, 2020

01:46PM EDT Exact Sciences Shares Quiet Following FDA Comment, On Aug. 28, Request To Update Instructions For Use Of Coronavirus Vaccine Test To Include Co.'s Home Collection Kit For Nasal Swab Collection Was Granted Benzinga

10:24AM EDT Exact Sciences Shares Spike Higher; Hearing Traders Circulate Chatter Of EUA Approval For Coronavirus Home Kit Benzinga

Aug 4, 2020

11:15AM EDT Exact Sciences Shares Moving Higher; Traders Circulate Fact Sheet For N Gene Detection Coronavirus Test Benzinga

Aug 3, 2020

06:00AM EDT Exact Sciences to participate in August investor conference PR Newswire

Jul 31, 2020

06:41AM EDT SVB Leerink Maintains Outperform on Exact Sciences, Raises Price Target to $115 Benzinga

Jul 30, 2020

04:12PM EDT Exact Sciences Q2 EPS $(0.58) Beats $(0.63) Estimate, Sales $268.90M Beat $228.42M Estimate Benzinga

04:05PM EDT Exact Sciences Announces Second Quarter 2020 Results PR Newswire

04:06AM EDT Earnings Scheduled For July 30, 2020 Benzinga

Jul 20, 2020

02:13PM EDT Exact Sciences Option Alert: Jan 15 $145 Calls at the Ask: 1000 @ $2.451 vs 149 OI; Earnings 7/30 After Close Ref=$99.915 Benzinga

document.getElementById("JDFpQq").onerror = function(){this.style.display='none';}; .dark-mode .kfzZCz{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .kfzZCz{ color: #333333; background-color: white; border: 2px solid #333333; }EXASExact Sciences Corpstock NASDAQ

EXAS
Exact Sciences Corp
stock NASDAQ